Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiation
- 26 July 2001
- journal article
- Published by Springer Nature in Leukemia
- Vol. 15 (8) , 1232-1239
- https://doi.org/10.1038/sj.leu.2402179
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 41 references indexed in Scilit:
- Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivoNature Medicine, 1999
- Protein Kinase Cι Activity Is Necessary for Bcr-Abl-mediated Resistance to Drug-induced ApoptosisJournal of Biological Chemistry, 1999
- Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR–ABL tyrosine kinase, CGP 57148Cell Death & Differentiation, 1998
- Bcl-2-independent Bcr–Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xLOncogene, 1998
- Activation of β1 integrins on CML progenitors reveals cooperation between β1 integrins and CD44 in the regulation of adhesion and proliferationLeukemia, 1997
- The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cellsLeukemia Research, 1996
- Apoptosis induced by inhibition of intercellular contact.The Journal of cell biology, 1994
- The extracellular matrix as a cell survival factor.Molecular Biology of the Cell, 1993
- Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitroScience, 1992
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990